Search Results | Cancer Research | American Association for Cancer Research

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Abstract P4-02-03: HER1-4 protein up-regulation following short-term neoadjuvant endocrine therapy in patients with hormone receptor-positive HER2-negative breast cancer

Lubna Naaz Chaudhary, Julie M Jorns, Yee Chung Cheng, Sailaja Kamaraju, John Burfeind, Mary Beth Gonyo, Amanda Kong, Caitlin Patten, Tina Yen, Chandler Cortina, Ebony Carson, Nedra Johnson, Carmen Bergom, Anjishnu Banerjee, Yu Wang, Yunguang Sun, Christopher R Chitambar, Hallgeir Rui

Cancer Res (2022) 82 (4_Supplement): P4-02-03.

DOI: https://doi.org/10.1158/1538-7445.SABCS21-P4-02-03

Published: 15 February 2022

View article

Journal Articles

Abstract PD7-07: Neoadjuvant endocrine therapy helps identify HER2 up-regulation in patients with hormone receptor-positive HER2-negative breast cancer

Lubna N Chaudhary, Julie M Jorns, Yee Chung Cheng, Sailaja Kamaraju, Mary Beth Gonyo, Amanda Kong, Caitlin Patten, Tina Yen, Chandler Cortina, Ebony Carson, Nedra Johnson, Carmen Bergom, Anjishnu Banerjee, Yu Wang, Christopher R Chitambar, Hallgeir Rui

Cancer Res (2021) 81 (4_Supplement): PD7-07.

DOI: https://doi.org/10.1158/1538-7445.SABCS20-PD7-07

Published: 15 February 2021

View article

Journal Articles

Abstract PS13-51: A phase II study of neoadjuvant weekly carboplatin/paclitaxel followed by dose-dense doxorubicin/cyclophosphamide (DD AC)in patients with triple negative breast cancer (TNBC): Wisconsin oncology network (WON) study

Yee Chung Cheng, Ruth O'Regan, Lubna N Chaudhary, Sailaja Kamaraju, Harvey Einhorn, Emmanuel Sampene, Marialane Pigsley, Mark E Burkard, Christopher R Chitambar, Kari B Wisinski

Cancer Res (2021) 81 (4_Supplement): PS13-51.

DOI: https://doi.org/10.1158/1538-7445.SABCS20-PS13-51

Published: 15 February 2021

View article

Journal Articles

Abstract 4176: Involvement of the lysosome in the cytotoxicity of Gallium Maltolate in human pediatric brain tumor cell lines

Salvatore Molino, Christopher R. Chitambar

Cancer Res (2020) 80 (16_Supplement): 4176.

DOI: https://doi.org/10.1158/1538-7445.AM2020-4176

Published: 15 August 2020

View article

Journal Articles

Abstract P2-12-08: Chemotherapy-induced fatigue and mitochondrial function in early stage breast cancer

Kanchana Herath, Brian P Dranka, George M Lessmann, Donna McAllister, Raymond G Hoffmann, Balaraman Kalyanaraman, Christopher R Chitambar, Namrata I Peswani

Cancer Res (2015) 75 (9_Supplement): P2-12-08.

DOI: https://doi.org/10.1158/1538-7445.SABCS14-P2-12-08

Published: 01 May 2015

View article

Journal Articles

Abstract P4-11-31: Inverse relationship between ER+/PR- breast cancer and OncotypeDx scores and concordance between IHC and RT-PCR

Lubna N Chaudhary, Zeeshan Jawa, Aniko Szabo, Alexis Visotcky, Christopher R Chitambar

Cancer Res (2015) 75 (9_Supplement): P4-11-31.

DOI: https://doi.org/10.1158/1538-7445.SABCS14-P4-11-31

Published: 01 May 2015

View article

Journal Articles

Abstract 5606: Gallium maltolate inhibits brain tumor volume and blood volume in xenograft model.

Kimberly R. Pechman, Andrew Lozen, Mona Al-Gizawiy, Kathleen Schmainda, Christopher R. Chitambar

Cancer Res (2013) 73 (8_Supplement): 5606.

DOI: https://doi.org/10.1158/1538-7445.AM2013-5606

Published: 15 April 2013

View article

Journal Articles

Abstract 2654: A prospective study of the effects of adjuvant chemotherapy (CT) on cognition and brain function in breast cancer patients

Alicia Barr, William Collier, Linda Piacentine, Kelli Douville, Sally Durgerian, Peter LaViolette, David Sabsevitz, Kathleen Schmainda, Christopher R. Chitambar, Alan Bloom

Cancer Res (2012) 72 (8_Supplement): 2654.

DOI: https://doi.org/10.1158/1538-7445.AM2012-2654

Published: 15 April 2012

View article

Journal Articles

Abstract 2152: p38α MAPK regulates signal transduction between estrogen receptor (ER) and its antagonist by switching ER signaling from the classical to the non-classical pathway

Guan Chen, Huiying Zhi, Songwang Hou, Phillip Wang, Jian Huang, Zainab Basir, Christopher R. Chitambar, Xiaomei Qi

Cancer Res (2012) 72 (8_Supplement): 2152.

DOI: https://doi.org/10.1158/1538-7445.AM2012-2152

Published: 15 April 2012

View article

Journal Articles

Development of gallium compounds for the treatment of non-Hodgkin’s lymphoma: Gallium maltolate as a novel agent with broad-spectrum activity against diverse lymphoma cell types.

Christopher R. Chitambar, Thomas P. Joseph, Dianah Marable, Janine P. Wereley

Cancer Res (2006) 66 (8_Supplement): 1284.

Published: 15 April 2006

View article

Journal Articles

Gallium nitrate as a novel agent for the treatment of mantle cell lymphoma: Targets and mechanisms of action

Thomas P. Joseph, Janine P. Wereley, Christopher R. Chitambar

Cancer Res (2005) 65 (9_Supplement): 1383–1384.

Published: 01 May 2005

View article

Journal Articles

Mechanisms of antineoplastic activity of gallium nitrate in lymphoma: Protein ubiquitination and the induction of apoptosis through a Bax and mitochondrial pathway

Christopher R. Chitambar, Janine P. Wereley, Shigemi Matsuyama

Cancer Res (2004) 64 (7_Supplement): 1226.

Published: 01 April 2004

View article

Journal Articles

Effect of Hydroxyurea on Cellular Iron Metabolism in Human Leukemic CCRF-CEM Cells: Changes in Iron Uptake and the Regulation of Transferrin Receptor and Ferritin Gene Expression following Inhibition of DNA Synthesis

Christopher R. Chitambar, Janine P. Wereley

Cancer Res (1995) 55 (19): 4361–4366.

Published: 01 October 1995

View article

Journal Articles

Synergistic Inhibition of T-Lymphoblastic Leukemic CCRF-CEM Cell Growth by Gallium and Recombinant Human α-Interferon through Action on Cellular Iron Uptake

Christopher R. Chitambar, Janine P. Wereley, Riaz-Ul-Haq

Cancer Res (1994) 54 (12): 3224–3228.

Published: 01 June 1994

View article

Journal Articles

Inhibition of Ribonucleotide Reductase by Gallium in Murine Leukemic L1210 Cells

Christopher R. Chitambar, Jana Narasimhan, Julie Guy, Daniel S. Sem, William J. O'Brien

Cancer Res (1991) 51 (22): 6199–6201.

Published: 01 November 1991

View article

Journal Articles

Interaction of Gallium Nitrate with Fludarabine and Iron Chelators: Effects on the Proliferation of Human Leukemic HL60 Cells

Joel H. Lundberg, Christopher R. Chitambar

Cancer Res (1990) 50 (20): 6466–6470.

Published: 01 October 1990

View article

Journal Articles

Development of Drug Resistance to Gallium Nitrate through Modulation of Cellular Iron Uptake

Christopher R. Chitambar, Zorica Zivkovic-Gilgenbach, Jana Narasimhan, William E. Antholine

Cancer Res (1990) 50 (15): 4468–4472.

Published: 01 August 1990

View article

Journal Articles

Role of the Acidic Receptosome in the Uptake and Retention of ⁶⁷Ga by Human Leukemic HL60 Cells

Christopher R. Chitambar, Zorica Zivkovic-Gilgenbach

Cancer Res (1990) 50 (5): 1484–1487.

Published: 01 March 1990

View article

Journal Articles

Modulation of Lymphocyte Proliferation and Immunoglobulin Production by Transferrin-Gallium

Christopher R. Chitambar, Margaret C. Seigneuret, William G. Matthaeus, Lawrence G. Lum

Cancer Res (1989) 49 (5): 1125–1129.

Published: 01 March 1989

View article

Journal Articles

Uptake of Gallium-67 by Human Leukemic Cells: Demonstration of Transferrin Receptor-dependent and Transferrin-independent Mechanisms

Christopher R. Chitambar, Zorica Zivkovic

Cancer Res (1987) 47 (15): 3929–3934.

Published: 01 August 1987

View article

NARROW

Abstract P4-02-03: HER1-4 protein up-regulation following short-term neoadjuvant endocrine therapy in patients with hormone receptor-positive HER2-negative breast cancer

Abstract PD7-07: Neoadjuvant endocrine therapy helps identify HER2 up-regulation in patients with hormone receptor-positive HER2-negative breast cancer

Abstract PS13-51: A phase II study of neoadjuvant weekly carboplatin/paclitaxel followed by dose-dense doxorubicin/cyclophosphamide (DD AC)in patients with triple negative breast cancer (TNBC): Wisconsin oncology network (WON) study

Abstract 4176: Involvement of the lysosome in the cytotoxicity of Gallium Maltolate in human pediatric brain tumor cell lines

Abstract P2-12-08: Chemotherapy-induced fatigue and mitochondrial function in early stage breast cancer

Abstract P4-11-31: Inverse relationship between ER+/PR- breast cancer and OncotypeDx scores and concordance between IHC and RT-PCR

Abstract 5606: Gallium maltolate inhibits brain tumor volume and blood volume in xenograft model.

Abstract 2654: A prospective study of the effects of adjuvant chemotherapy (CT) on cognition and brain function in breast cancer patients

Abstract 2152: p38α MAPK regulates signal transduction between estrogen receptor (ER) and its antagonist by switching ER signaling from the classical to the non-classical pathway

Development of gallium compounds for the treatment of non-Hodgkin’s lymphoma: Gallium maltolate as a novel agent with broad-spectrum activity against diverse lymphoma cell types.

Gallium nitrate as a novel agent for the treatment of mantle cell lymphoma: Targets and mechanisms of action

Mechanisms of antineoplastic activity of gallium nitrate in lymphoma: Protein ubiquitination and the induction of apoptosis through a Bax and mitochondrial pathway

Effect of Hydroxyurea on Cellular Iron Metabolism in Human Leukemic CCRF-CEM Cells: Changes in Iron Uptake and the Regulation of Transferrin Receptor and Ferritin Gene Expression following Inhibition of DNA Synthesis

Synergistic Inhibition of T-Lymphoblastic Leukemic CCRF-CEM Cell Growth by Gallium and Recombinant Human α-Interferon through Action on Cellular Iron Uptake

Inhibition of Ribonucleotide Reductase by Gallium in Murine Leukemic L1210 Cells

Interaction of Gallium Nitrate with Fludarabine and Iron Chelators: Effects on the Proliferation of Human Leukemic HL60 Cells

Development of Drug Resistance to Gallium Nitrate through Modulation of Cellular Iron Uptake

Role of the Acidic Receptosome in the Uptake and Retention of ⁶⁷Ga by Human Leukemic HL60 Cells

Modulation of Lymphocyte Proliferation and Immunoglobulin Production by Transferrin-Gallium

Uptake of Gallium-67 by Human Leukemic Cells: Demonstration of Transferrin Receptor-dependent and Transferrin-independent Mechanisms

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only